Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Ceugnart

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
La Revue Du Praticien|March 19, 2021
[What future for the French Breast Cancer Screening Program ?]Luc Ceugnart
Bulletin Du Cancer|January 31, 2008
[Breast MR imaging: validated indications and unsolved problems]Sophie Taïeb, Luc Ceugnart
Bulletin Du Cancer|December 22, 2006
[Imaging and cancers]Luc Ceugnart, Sophie Taïeb
Bulletin Du Cancer|December 22, 2006
[Interest of imaging for the monitoring of a treated cancer: simplified use of likelyhood ratio. The example of soft tissue tumor]Sophie Taieb, Nicolas Penel, Luc Ceugnart
Presse Medicale (Paris, France : 1983)|November 3, 2019
[Breast cancer: News tools in imaging]Luc Ceugnart, Anais Olivier, Aurore Oudoux
European Journal of Radiology|June 13, 2009
Soft tissue sarcomas or intramuscular haematomas?Sophie Taïeb, Nicolas Penel, Luc Vanseymortier, et al.
Bulletin Du Cancer|December 3, 2011
[Endometrial cancer imaging]Sophie Taïeb, Nathalie Rocourt, Fabrice Narducci, et al.
Bulletin Du Cancer|February 4, 2020
[Magnetic resonance imaging of desmoid-type fibromatosis: Current evaluation criteria]Mariem Ben Haj Amor, Loïc Ploton, Luc Ceugnart, et al.
Bulletin Du Cancer|July 31, 2025
[Prevalence of breast arterial calcification in women who underwent a breast cancer screening in the Hauts-de-France]Anissa Assaf, Marie-Laure Forzy, Valérie Pétigny, et al.
European Journal of Radiology|January 20, 2016
BIRADS 3 MRI lesions: Was the initial score appropriate and what is the value of the blooming sign as an additional parameter to better characterize these lesions?Ralphy Guillaume, Sophie Taieb, Luc Ceugnart, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
La Revue Du Praticien|March 19, 2021
[What future for the French Breast Cancer Screening Program ?]Luc Ceugnart
Bulletin Du Cancer|January 31, 2008
[Breast MR imaging: validated indications and unsolved problems]Sophie Taïeb, Luc Ceugnart
Bulletin Du Cancer|December 22, 2006
[Imaging and cancers]Luc Ceugnart, Sophie Taïeb
Bulletin Du Cancer|December 22, 2006
[Interest of imaging for the monitoring of a treated cancer: simplified use of likelyhood ratio. The example of soft tissue tumor]Sophie Taieb, Nicolas Penel, Luc Ceugnart
Presse Medicale (Paris, France : 1983)|November 3, 2019
[Breast cancer: News tools in imaging]Luc Ceugnart, Anais Olivier, Aurore Oudoux
European Journal of Radiology|June 13, 2009
Soft tissue sarcomas or intramuscular haematomas?Sophie Taïeb, Nicolas Penel, Luc Vanseymortier, et al.
Bulletin Du Cancer|December 3, 2011
[Endometrial cancer imaging]Sophie Taïeb, Nathalie Rocourt, Fabrice Narducci, et al.
Bulletin Du Cancer|February 4, 2020
[Magnetic resonance imaging of desmoid-type fibromatosis: Current evaluation criteria]Mariem Ben Haj Amor, Loïc Ploton, Luc Ceugnart, et al.
Bulletin Du Cancer|July 31, 2025
[Prevalence of breast arterial calcification in women who underwent a breast cancer screening in the Hauts-de-France]Anissa Assaf, Marie-Laure Forzy, Valérie Pétigny, et al.
European Journal of Radiology|January 20, 2016
BIRADS 3 MRI lesions: Was the initial score appropriate and what is the value of the blooming sign as an additional parameter to better characterize these lesions?Ralphy Guillaume, Sophie Taieb, Luc Ceugnart, et al.
Pageof 5